A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
出版年份 2014 全文链接
标题
A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
作者
关键词
-
出版物
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume 15, Issue 5-6, Pages 406-413
出版商
Informa UK Limited
发表日期
2014-08-15
DOI
10.3109/21678421.2014.943672
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Journal Club: Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology
- (2014) J. R. Brosch et al. NEUROLOGY
- Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
- (2013) Merit E Cudkowicz et al. LANCET NEUROLOGY
- Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
- (2013) LANCET NEUROLOGY
- Controversies and priorities in amyotrophic lateral sclerosis
- (2013) Martin R Turner et al. LANCET NEUROLOGY
- The changing scene of amyotrophic lateral sclerosis
- (2013) Wim Robberecht et al. NATURE REVIEWS NEUROSCIENCE
- Pearls and Oy-sters: Tuberculous meningitis: Not a diagnosis of exclusion
- (2013) A. C. Jongeling et al. NEUROLOGY
- Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis
- (2013) James D. Berry et al. PLoS One
- Infrastructure resources for clinical research in amyotrophic lateral sclerosis
- (2013) Alexander V. Sherman et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis
- (2013) John Ravits et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- The Combined Assessment of Function and Survival (CAFS): A new endpoint for ALS clinical trials
- (2013) James D. Berry et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Prognostic categories for amyotrophic lateral sclerosis
- (2012) William J. Scotton et al. Amyotrophic Lateral Sclerosis
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study
- (2012) Virginia Devonshire et al. LANCET NEUROLOGY
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biochemical alterations associated with ALS
- (2011) Kay A. Lawton et al. Amyotrophic Lateral Sclerosis
- Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
- (2011) Gavin Giovannoni et al. LANCET NEUROLOGY
- The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
- (2011) Merit Cudkowicz et al. NATURE MEDICINE
- Toward more efficient clinical trials for amyotrophic lateral sclerosis
- (2009) Merit E. Cudkowicz et al. Amyotrophic Lateral Sclerosis
- Prognostic factors in ALS: A critical review
- (2009) Adriano Chiò et al. Amyotrophic Lateral Sclerosis
- Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials
- (2009) Xin Sun et al. Trials
- Biomarkers in amyotrophic lateral sclerosis
- (2008) Martin R Turner et al. LANCET NEUROLOGY
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
- (2008) E. J. Sorenson et al. NEUROLOGY
- Designing Clinical Trials in Amyotrophic Lateral Sclerosis
- (2008) Jeremy M. Shefner Physical Medicine and Rehabilitation Clinics of North America
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started